Skip to main content
PMC home page
Gut logoLink to Gut
. 1999 Aug;45(2):284–288. doi: 10.1136/gut.45.2.284

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan

H Marusawa 1, Y Osaki 1, T Kimura 1, K Ito 1, Y Yamashita 1, T Eguchi 1, M Kudo 1, Y Yamamoto 1, H Kojima 1, H Seno 1, F Moriyasu 1, T Chiba 1
PMCID: PMC1727594  PMID: 10403743

Abstract

BACKGROUND/AIMS—Evidence is accumulating that hepatitis B virus (HBV) is present in patients who are hepatitis B surface antigen negative but have antibody to hepatitis B core antigen (anti-HBc). Furthermore, recent studies have shown that patients with hepatocellular carcinoma who have antibody to hepatitis C virus (HCV) often possess HBV related serological markers. Data on the seroprevalence of HBV infection in patients with HCV related chronic liver disease were collected to evaluate the significance of the presence of antibodies to HBV.
METHODS—The prevalence of HBV related serological markers was analysed in a total of 2014 Japanese patients with HCV infection. The control group comprised 352 subjects without liver disorder.
RESULTS—A large number of patients (49.9%) with HCV related chronic liver disease including hepatocellular carcinoma were positive for anti-HBc. In addition, the prevalence of anti-HBc closely correlated with the clinical stage of the liver disease. There was no relation between a past history of blood transfusion and the prevalence of anti-HBc. Notably, anti-HBc was the only serological marker for HBV infection in a significant number of patients with HCV related chronic liver disease (24.1%).
CONCLUSIONS—Our data provide further evidence for the high prevalence of anti-HBc in patients with HCV related chronic liver disease, particularly those with hepatocellular carcinoma, suggesting that HBV infection, probably including latent infection, may play an important role in carcinogenesis in these patients.


Keywords: hepatitis B virus; anti-HBc; hepatitis C virus; hepatocellular carcinoma

Full Text

The Full Text of this article is available as a PDF (85.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blum H. E., Liang T. J., Galun E., Wands J. R. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology. 1991 Jul;14(1):56–63. doi: 10.1002/hep.1840140110. [DOI] [PubMed] [Google Scholar]
  2. Brechot C., Pourcel C., Louise A., Rain B., Tiollais P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 1980 Jul 31;286(5772):533–535. doi: 10.1038/286533a0. [DOI] [PubMed] [Google Scholar]
  3. Bréchot C., Degos F., Lugassy C., Thiers V., Zafrani S., Franco D., Bismuth H., Trépo C., Benhamou J. P., Wands J. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med. 1985 Jan 31;312(5):270–276. doi: 10.1056/NEJM198501313120503. [DOI] [PubMed] [Google Scholar]
  4. Chiba T., Matsuzaki Y., Abei M., Shoda J., Tanaka N., Osuga T., Aikawa T. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol. 1996 Jun;91(6):1195–1203. [PubMed] [Google Scholar]
  5. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  6. De Mitri M. S., Poussin K., Baccarini P., Pontisso P., D'Errico A., Simon N., Grigioni W., Alberti A., Beaugrand M., Pisi E. HCV-associated liver cancer without cirrhosis. Lancet. 1995 Feb 18;345(8947):413–415. doi: 10.1016/s0140-6736(95)90400-x. [DOI] [PubMed] [Google Scholar]
  7. Dickson R. C., Everhart J. E., Lake J. R., Wei Y., Seaberg E. C., Wiesner R. H., Zetterman R. K., Pruett T. L., Ishitani M. B., Hoofnagle J. H. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology. 1997 Nov;113(5):1668–1674. doi: 10.1053/gast.1997.v113.pm9352871. [DOI] [PubMed] [Google Scholar]
  8. Edamoto Y., Tani M., Kurata T., Abe K. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues. Cancer. 1996 May 1;77(9):1787–1791. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1787::AID-CNCR5>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  9. Fong T. L., Di Bisceglie A. M., Gerber M. A., Waggoner J. G., Hoofnagle J. H. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology. 1993 Dec;18(6):1313–1318. [PubMed] [Google Scholar]
  10. Hoofnagle J. H., Gerety R. J., Ni L. Y., Barker L. F. Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication. N Engl J Med. 1974 Jun 13;290(24):1336–1340. doi: 10.1056/NEJM197406132902402. [DOI] [PubMed] [Google Scholar]
  11. Iizuka H., Ohmura K., Ishijima A., Satoh K., Tanaka T., Tsuda F., Okamoto H., Miyakawa Y., Mayumi M. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang. 1992;63(2):107–111. doi: 10.1111/j.1423-0410.1992.tb02495.x. [DOI] [PubMed] [Google Scholar]
  12. Ikeda K., Saitoh S., Koida I., Arase Y., Tsubota A., Chayama K., Kumada H., Kawanishi M. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993 Jul;18(1):47–53. [PubMed] [Google Scholar]
  13. Jilg W., Sieger E., Zachoval R., Schätzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol. 1995 Jul;23(1):14–20. doi: 10.1016/0168-8278(95)80305-x. [DOI] [PubMed] [Google Scholar]
  14. Kuhns M., McNamara A., Mason A., Campbell C., Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology. 1992 Nov;103(5):1649–1656. doi: 10.1016/0016-5085(92)91191-6. [DOI] [PubMed] [Google Scholar]
  15. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  16. Lai M. Y., Chen P. J., Yang P. M., Sheu J. C., Sung J. L., Chen D. S. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology. 1990 Sep;12(3 Pt 1):575–581. doi: 10.1002/hep.1840120321. [DOI] [PubMed] [Google Scholar]
  17. Liang T. J., Jeffers L. J., Reddy K. R., De Medina M., Parker I. T., Cheinquer H., Idrovo V., Rabassa A., Schiff E. R. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology. 1993 Dec;18(6):1326–1333. [PubMed] [Google Scholar]
  18. Michalak T. I., Pasquinelli C., Guilhot S., Chisari F. V. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 1994 Jan;93(1):230–239. doi: 10.1172/JCI116950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nishioka K., Watanabe J., Furuta S., Tanaka E., Iino S., Suzuki H., Tsuji T., Yano M., Kuo G., Choo Q. L. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer. 1991 Jan 15;67(2):429–433. doi: 10.1002/1097-0142(19910115)67:2<429::aid-cncr2820670218>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  20. Ohkoshi S., Kojima H., Tawaraya H., Miyajima T., Kamimura T., Asakura H., Satoh A., Hirose S., Hijikata M., Kato N. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn J Cancer Res. 1990 Jun-Jul;81(6-7):550–553. doi: 10.1111/j.1349-7006.1990.tb02605.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Paterlini P., Gerken G., Nakajima E., Terre S., D'Errico A., Grigioni W., Nalpas B., Franco D., Wands J., Kew M. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med. 1990 Jul 12;323(2):80–85. doi: 10.1056/NEJM199007123230202. [DOI] [PubMed] [Google Scholar]
  22. Penna A., Artini M., Cavalli A., Levrero M., Bertoletti A., Pilli M., Chisari F. V., Rehermann B., Del Prete G., Fiaccadori F. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest. 1996 Sep 1;98(5):1185–1194. doi: 10.1172/JCI118902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pontisso P., Ruvoletto M. G., Fattovich G., Chemello L., Gallorini A., Ruol A., Alberti A. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology. 1993 Nov;105(5):1529–1533. doi: 10.1016/0016-5085(93)90161-5. [DOI] [PubMed] [Google Scholar]
  24. Rehermann B., Ferrari C., Pasquinelli C., Chisari F. V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996 Oct;2(10):1104–1108. doi: 10.1038/nm1096-1104. [DOI] [PubMed] [Google Scholar]
  25. Ruiz J., Sangro B., Cuende J. I., Beloqui O., Riezu-Boj J. I., Herrero J. I., Prieto J. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology. 1992 Sep;16(3):637–641. doi: 10.1002/hep.1840160305. [DOI] [PubMed] [Google Scholar]
  26. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6547–6549. doi: 10.1073/pnas.87.17.6547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shih C. M., Lo S. J., Miyamura T., Chen S. Y., Lee Y. H. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol. 1993 Oct;67(10):5823–5832. doi: 10.1128/jvi.67.10.5823-5832.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shiratori Y., Shiina S., Imamura M., Kato N., Kanai F., Okudaira T., Teratani T., Tohgo G., Toda N., Ohashi M. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology. 1995 Oct;22(4 Pt 1):1027–1033. doi: 10.1016/0270-9139(95)90605-3. [DOI] [PubMed] [Google Scholar]
  29. Tanaka K., Hirohata T., Koga S., Sugimachi K., Kanematsu T., Ohryohji F., Nawata H., Ishibashi H., Maeda Y., Kiyokawa H. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res. 1991 Jun 1;51(11):2842–2847. [PubMed] [Google Scholar]
  30. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993 Jun 24;328(25):1797–1801. doi: 10.1056/NEJM199306243282501. [DOI] [PubMed] [Google Scholar]
  31. Uemoto S., Sugiyama K., Marusawa H., Inomata Y., Asonuma K., Egawa H., Kiuchi T., Miyake Y., Tanaka K., Chiba T. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation. 1998 Feb 27;65(4):494–499. doi: 10.1097/00007890-199802270-00007. [DOI] [PubMed] [Google Scholar]
  32. Urashima T., Saigo K., Kobayashi S., Imaseki H., Matsubara H., Koide Y., Asano T., Kondo Y., Koike K., Isono K. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues. J Hepatol. 1997 Apr;26(4):771–778. doi: 10.1016/s0168-8278(97)80241-3. [DOI] [PubMed] [Google Scholar]
  33. Yu M. W., You S. L., Chang A. S., Lu S. N., Liaw Y. F., Chen C. J. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res. 1991 Oct 15;51(20):5621–5625. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES